Financial challenges are the No. 1 barrier patients cite to getting a blood stem cell transplant. Each day, NMDP receives 15 grant requests from patients needing help with transplant-related expenses ...
SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor ...
A $3 million donation from Big Nova supports NMDP programs that reduce barriers to blood stem cell transplants.
(This video is no longer available for streaming.) In this story from January 2006, NOVA scienceNOW reports on stunning developments in the field of stem cell research. The South Korean scientist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback